Healthcare

Request for TOC Request for Sample
BUY NOW

Middle East and Africa At-Home Testing Kits Market – Industry Trends and Forecast to 2029

Healthcare | Published Report | Aug 2022 | MEA | 350 Pages | No of Tables: 105 | No of Figures: 44

Report Description

Middle East and Africa At-Home Testing Kits Market, By Test Type (Pregnancy Test, HIV Test Kit, Diabetes, Infectious Diseases, Glucose Tests, Ovulation Predictor Test Kit, Drug Abuse Test Kit, and Others), Type (Cassette, Strip, Midstream, Test Panel, Dip Card and Others), Age (Pediatric, Adult and Geriatric), Sample Type (Urine, Blood, Saliva and Other Sample Types), Usage (Disposable and Reusable), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket and Online Pharmacies)- Industry Trends and Forecast to 2029.

Get Exclusive Sample Copy of this Report Here

Middle East and Africa At-Home Testing Kits Market Analysis and Insights

Middle East and Africa at-home testing kits market is expected to grow as earlier, people used to visit hospitals often, even for basic problems, but due to the rising awareness regarding several products, this behavior has changed and has turned the trend. At-home or self-testing kits are easily available at pharmacies, and it has become extremely easy to procure them. Various medical companies are venturing into this space as they rapidly manufacture self-test kits.

Get Exclusive Sample Copy of this Report Here

Get Exclusive Sample Copy of this Report Here

This widespread availability can also be attributed to online pharmacies' medical start-ups, making availability easier by clicking a button. In addition, these self-testing kits are available without any prescription which can easily drive the at-home testing kits market. At-home testing kits allow end-users to collect their specimen at home and then either perform the tests at home or send that specimen to the lab for testing. At-home testing kits have undoubtedly eased the process of confirming the person's concern, whether it is a home pregnancy test or HIV, or any other infectious diseases test.

These at-home testing kits are easy to use and are affordable too. However, there is always a doubt about the accuracy of the results that has become a restraint for the Middle East and Africa at-home testing kits market. A false positive result of a test may cause anxiety and stress to the person, even if they do not have it. It is very upsetting and disturbing to the person to receive false positive or negative results. Today, many companies produce rapid diagnostic test kits for COVID-19, which can be performed at home. But there are various accuracy-related issues due to which the distribution of those at-home test kits that has been suspended from verifying their reliability.

Data Bridge Market Research analyzes that the Middle East and Africa at-home testing kits market will grow at a CAGR of 4.5% during the forecast period of 2022 to 2029.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019-2014)

Quantitative Units

Revenue in USD Million, Pricing in USD

Segments Covered

By Test Type (Pregnancy Test, HIV Test Kit, Diabetes, Infectious Diseases, Glucose Tests, Ovulation Predictor Test Kit, Drug Abuse Test Kit, and Others), Type (Cassette, Strip, Midstream, Test Panel, Dip Card and Others), Age (Pediatric, Adult and Geriatric), Sample Type (Urine, Blood, Saliva and Other Sample Types), Usage (Disposable and Reusable), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket and Online Pharmacies)

Countries Covered

South Africa, Saudi Arabia, U.A.E, Israel, Egypt and Rest of Middle East and Africa

Market Players Covered

Abbott, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, BD, Drägerwerk AG & Co. KGaA, LifeScan IP Holdings, LLC, Ascensia Diabetes Care Holdings AG., Nectar Lifesciences Ltd. (Rapikit), ACON Laboratories, Inc., Quidel Corporation., ARKRAY USA, Inc., BTNX INC., Atomo Diagnostics, Eurofins Scientific, Piramal Enterprises Ltd., Bionime Corporation., Nova Biomedical, Cardinal Health., OraSure Technologies, Biolytical Laboratories Inc., Everlywell, Inc., SA Scientific Ltd., Clearblue (a subsidiary of Swiss Precision Diagnostics GmbH), Biosynex, PRIMA Lab SA, MP BIOMEDICALS., Sterilab Services, Chembio Diagnostics, Inc., BioSure, Selfdiagnostics OU among others

Middle East and Africa At-Home Testing Kits Market Definition

At-home testing kits means testing instruments which help people to perform tests at home and give them rapid results in a minute. It also includes health monitoring equipment to continuously check and control the health of the diabetic patient. At-home tests are very convenient to perform with comfort at home and are available at very affordable rate. Self-tests are usually the advance versions of rapid, point-of-care test kits that were originally designed for healthcare professionals and can be performed by common person. Their processes, packaging and instructions have been simplified so as to guide person through the steps of taking a test. Various at-home test kits are available including HIV tests, pregnancy test, diabetes, ovulation test, and infectious diseases such as malaria, COVID-19, and others.  For performing these rapid at-home tests, blood, urine, and oral fluid can be taken as a sample.

Middle East and Africa At-Home Testing Kits Market Dynamics

Drivers

  • Growing adoption of self-testing kits

Earlier, people used to visit hospitals often, even for basic problems. However, as awareness has grown regarding several products, this behavior has changed and has turned the trend. Nowadays, people prefer to get their basic tests done using test kits at home before visiting a doctor.

This has become even more prominent due to this pandemic as people are adopting more self-help testing kits due to several restrictions in place. It has turned out to be a boon in disguise for both hospitals and patients as hospitals are already stretched thin and can entirely focus on COVID-19 patients, and the patients can save hefty costs of doctor visits and medicine fees. It has become highly convenient for consumers as they can quickly know their tests' results at their fingertips.

  • Easy availability of self-testing kits at pharmacies

At-home or self-testing kits are easily available at pharmacies, and it has become effortless to procure them. Various medical companies are venturing into this space as they rapidly manufacture self-test kits.

This widespread availability can also be attributed to online pharmacies' medical start-ups, making availability easier by clicking a button. In addition, these self-testing kits are available without any prescription.

Opportunity

  • Advent of advanced technologies

The latest technologies are crucial in making medical products very advanced and reliable to trust. In different medical devices, Artificial Intelligence (AI) and Machine Learning (ML) are important aspects of the healthcare sector with the ability to enhance patient safety and administrative processes by work automation and quicker performance.

It is certain that, by default, AI-powered diagnostic instruments will continue to develop. AI has only taken modest moves into a huge and multi-dimensional opportunity in the healthcare sector.

Restraint/Challenge

  • Inaccuracy of results by self-testing kits

At-home testing kits allow end-users to collect their specimen at home and perform the tests at home or send that specimen to the lab for testing. At-home testing kits have undoubtedly eased the process of confirming the person's concern, whether it is a home pregnancy test, HIV test, or any other infectious diseases test.

These at-home testing kits are easy to use and are affordable too. However, there is always a doubt about the accuracy of the results. COVID-19 home monitoring can be more comfortable than going to a hospital or doctor's office. It will also help reduce the risk of the coronavirus being spread or acquired when you are screened.

However, a false positive test result may cause anxiety and stress to the person, even if they do not have it. It is very upsetting and disturbing to the person to receive false positive or negative results. Today, many companies produce rapid diagnostic test kits for COVID-19 which can be performed at home, but there are various accuracy-related issues due to which the distribution of those at-home test kits has been suspended from verifying their reliability.

Post COVID-19 Impact on Middle East and Africa At-Home Testing Kits Market

COVID-19 created a great impact on the Middle East and Africa at-home testing kits market. The market for at-home testing kits is expanding as a consequence of the increased popularity of self-help and Do-It-Yourself (DIY) test kits due to their convenience and quick results. Consumers have concerns about the dependability of rapid home testing kits, which could impede the market's expansion for at-home testing kits. Rapid testing kits for COVID-19 are now urgently needed by companies in order to reduce patient deaths and boost patient recovery rates and also increased rate for the at home testing kits market for Diabetic patients and patients having heart problems. This is creating a major market opportunity for at-home testing kits.

Recent Development

  • In December 2021, Siemens Healthineers had announced that the company’s CLINITEST Rapid COVID-19 Antigen Self-Test can detect the omicron SARS-CoV-2 variant. This is a great achievement for the company to detect such dangerous variant through their test. This had helped the company to increase their revenue in the market and grow their presence

Middle East and Africa At-Home Testing Kits Market Scope

Middle East and Africa at-home testing kits market is categorized into six notable segments based on test type, type, age, sample type, usage, and distribution channels. The growth amongst these segments will help you analyze market growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Test Type

  • Pregnancy Test
  • HIV Test Kit
  • Diabetes
  • Infectious Diseases
  • Glucose Tests
  • Ovulation Predictor Test Kit
  • Drug Abuse Test Kit
  • Others

Based on test type, the Middle East and Africa at-home testing kits market is segmented into pregnancy test, HIV test kit, diabetes, infectious diseases, glucose tests, ovulation predictor test kit, drug abuse test kit, and others.

Type

  • Cassette
  • Strip
  • Midstream
  • Test Panel
  • Dip Card
  • Others

Based on type, the Middle East and Africa at-home testing kits market is segmented into cassette, strip, midstream, test panel, dip card, and others.

Age

  • Pediatric
  • Adult
  • Geriatric

Based on age, the Middle East and Africa at-home testing kits market is segmented into pediatric, adult, and geriatric.

Sample Type

  • Urine
  • Blood
  • Saliva
  • Others

Based on sample type, the Middle East and Africa at-home testing kits market is segmented into urine, blood, saliva, and others.

Usage

  • Disposable
  • Reusable

Based on usage, the Middle East and Africa at-home testing kits market is segmented into disposable and reusable.

Distribution Channels

  • Retail Pharmacies
  • Drug Store
  • Supermarket/Hypermarket
  • Online Pharmacies

Get Exclusive Sample Copy of this Report Here

Based on distribution channels, the Middle East and Africa at-home testing kits market is segmented into retail pharmacies, drug store, supermarket/hypermarket, and online pharmacies.

Middle East and Africa At-Home Testing Kits Market Regional Analysis/Insights

Middle East and Africa at-home testing kits market is analyzed and market size insights and trends are provided based on test type, type, age, sample type, usage and distribution channels.

The regions covered in the Middle East and Africa at-home testing kits market report are South Africa, Saudi Arabia, U.A.E, Israel, Egypt and Rest of Middle East and Africa.

South Africa dominates the Middle East and Africa at-home testing kits market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the country's high healthcare expenditure and the increasing awareness about the Middle East and Africa at-home testing kits market.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Middle East and Africa At-Home Testing Kits Market Share Analysis

Middle East and Africa at-home testing kits market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Middle East and Africa presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, brand analysis, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to the Middle East and Africa at-home testing kits market.

Some of the major players operating in the Middle East and Africa at-home testing kits market are Abbott, ACON Laboratories, Inc., Rapikit, BD, Cardinal Health, B. Braun Melsungen AG, Piramal Enterprises Ltd., Siemens Healthcare GmbH, Quidel Corporation, Bionime Corporation, SA Scientific, ARKRAY USA, Inc., Nova Biomedical, AdvaCare Pharma, AccuBioTech Co., Ltd., Atlas Medical UK, TaiDoc Technology Corporation, Drägerwerk AG & Co. KGaA, F. Hoffmann-La Roche Ltd, Sensing Self, PTE. Ltd, Atomo Diagnostics, RUNBIO BIOTECH CO.,LTD., Mylan N.V. (a subsidiary of Viatris, Inc.), MP BIOMEDICALS, VedaLab, Shanghai Chemtron Biotech Co.Ltd. and Ascensia Diabetes Care Holdings AG among other domestic players.


SKU-

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY TEST TYPE

2.8 MARKET POSITION COVERAGE GRID

2.9 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.1 DBMR MARKET POSITION GRID

2.11 DISTRIBUTOR CHANNEL ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER'S FIVE FORCES

5 MIDDLE EAST & AFRICA AT- HOME TESTING KITS MARKET: REGULATIONS

5.1 REGULATION IN U.S

5.2 GUIDELINES FOR SELF-TESTING KITS

5.3 REGULATION IN EUROPE

5.4 GUIDELINES FOR TESTING KITS

5.5 REGULATION IN INDONESIA:

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 GROWING ADOPTION OF SELF-TESTING KITS

6.1.2 EASY AVAILABILITY OF SELF-TESTING KITS AT PHARMACIES

6.1.3 INCREASE IN AWARENESS ABOUT THE IMPORTANCE OF HIV DIAGNOSIS

6.1.4 EASE OF USE AND LOW COSTS OF RAPID SELF-TEST KITS

6.2 RESTRAINTS

6.2.1 INACCURACY OF RESULTS BY SELF-TESTING KITS

6.2.2 STRINGENT GOVERNMENT REGULATIONS FOR MANUFACTURING AND DISTRIBUTION OF TESTING KITS

6.3 OPPORTUNITIES

6.3.1 ADVENT OF ADVANCED TECHNOLOGIES

6.3.2 EMERGING NEED FOR RAPID TESTING KITS FOR COVID-19 PANDEMIC

6.3.3 STRATEGIC INITIATIVES OF KEY PLAYERS

6.4 CHALLENGES

6.4.1 HIGH COMPETITION IN THE MEDICAL TECHNOLOGY INDUSTRY

6.4.2 REDUCTION IN RESEARCH & DEVELOPMENT BUDGETS

7 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY TEST TYPE

7.1 OVERVIEW

7.2 GLUCOSE TESTS

7.3 INFECTIOUS DISEASES

7.4 PREGNANCY TEST

7.5 DRUG ABUSE TEST KITS

7.6 HIV TEST KIT

7.7 OVULATION PREDICTOR TEST KIT

7.8 OTHERS TEST TYPES

8 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY TYPE

8.1 OVERVIEW

8.2 CASSETTES

8.2.1 RETAIL PHARMACIES

8.2.2 ONLINE PHARMACIES

8.2.3 DRUG STORE

8.2.4 SUPERMARKET/HYPERMARKET

8.3 STRIP

8.3.1 RETAIL PHARMACIES

8.3.2 ONLINE PHARMACIES

8.3.3 DRUG STORE

8.3.4 SUPERMARKET/HYPERMARKET

8.4 MIDSTREAM

8.4.1 RETAIL PHARMACIES

8.4.2 ONLINE PHARMACIES

8.4.3 DRUG STORE

8.4.4 SUPERMARKET/HYPERMARKET

8.5 DIP CARD

8.5.1 RETAIL PHARMACIES

8.5.2 ONLINE PHARMACIES

8.5.3 DRUG STORE

8.5.4 SUPERMARKET/HYPERMARKET

8.6 TEST PANEL

8.6.1 RETAIL PHARMACIES

8.6.2 ONLINE PHARMACIES

8.6.3 DRUG STORE

8.6.4 SUPERMARKET/HYPERMARKET

8.7 OTHERS

9 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY AGE

9.1 OVERVIEW

9.2 ADULT

9.3 GERIATRIC

9.4 PEDIATRIC

10 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE

10.1 OVERVIEW

10.2 BLOOD

10.3 URINE

10.4 SALIVA

10.5 OTHER SAMPLE TYPES

11 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY USAGE

11.1 OVERVIEW

11.2 DISPOSABLE

11.3 REUSABLE

12 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS

12.1 OVERVIEW

12.2 RETAIL PHARMACIES

12.3 ONLINE PHARMACIES

12.4 DRUG STORE

12.5 SUPERMARKET/HYPERMARKET

13 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY REGION

13.1 MIDDLE EAST & AFRICA

13.1.1 SOUTH AFRICA

13.1.2 SAUDI ARABIA

13.1.3 U.A.E

13.1.4 ISRAEL

13.1.5 EGYPT

13.1.6 REST OF MIDDLE EAST & AFRICA

14 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

15 SWOT ANALYSIS

16 COMPANY PROFILE

16.1 ABBOTT

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUS ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 PRODUCT PORTFOLIO

16.1.5 RECENT DEVELOPMENT

16.2 SIEMENS HEALTHCARE GMBH

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUS ANALYSIS

16.2.3 PRODUCT PORTFOLIO

16.2.4 RECENT DEVELOPMENTS

16.3 F. HOFFMANN- LA ROCHE LTD

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 COMPANY SHARE ANALYSIS

16.3.4 PRODUCT PORTFOLIO

16.3.5 RECENT DEVELOPMENTS

16.4 BD

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 PRODUCT PORTFOLIO

16.4.4 RECENT DEVELOPMENTS

16.5 DRÄGERWERK AG & CO. KGAA

16.5.1 COMPANY SNAPSHOT

16.5.2 REVENUE ANALYSIS

16.5.3 COMPANY SHARE ANALYSIS

16.5.4 PRODUCT PORTFOLIO

16.5.5 RECENT DEVELOPMENTS

16.6 LIFESCAN IP HOLDINGS, LLC

16.6.1 COMPANY SNAPSHOT

16.6.2 COMPANY SHARE ANALYSIS

16.6.3 PRODUCT PORTFOLIO

16.6.4 RECENT DEVELOPMENTS

16.7 ASCENSIA DIABETES CARE HOLDINGS AG.

16.7.1 COMPANY SNAPSHOT

16.7.2 COMPANY SHARE ANALYSIS

16.7.3 PRODUCT PORTFOLIO

16.7.4 RECENT DEVELOPMENTS

16.8 NECTAR LIFESCIENCES LTD. (RAPIKIT)

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCT PORTFOLIO

16.8.3 RECENT DEVELOPMENTS

16.9 ACON LABORATORIES, INC.

16.9.1 COMPANY SNAPSHOT

16.9.2 PRODUCT PORTFOLIO

16.9.3 RECENT DEVELOPMENTS

16.1 QUIDEL CORPORATION.

16.10.1 COMPANY SNAPSHOT

16.10.2 REVENUE ANALYSIS

16.10.3 PRODUCT PORTFOLIO

16.10.4 RECENT DEVELOPMENTS

16.11 ARKRAY USA, INC.

16.11.1 COMPANY SNAPSHOT

16.11.2 PRODUCT PORTFOLIO

16.11.3 RECENT DEVELOPMENTS

16.12 BTNX INC.

16.12.1 COMPANY SNAPSHOT

16.12.2 PRODUCT PORTFOLIO

16.12.3 RECENT DEVELOPMENTS

16.13 ATOMO DIAGNOSTICS

16.13.1 COMPANY SNAPSHOT

16.13.2 REVENUE ANALYSIS

16.13.3 PRODUCT PORTFOLIO

16.13.4 RECENT DEVELOPMENTS

16.14 EUROFINS SCIENTIFIC

16.14.1 COMPANY SNAPSHOT

16.14.2 REVENUE ANALYSIS

16.14.3 PRODUCT PORTFOLIO

16.14.4 RECENT DEVELOPMENTS

16.15 PIRAMAL ENTERPRISES LTD.

16.15.1 COMPANY SNAPSHOT

16.15.2 REVENUE ANALYSIS

16.15.3 PRODUCT PORTFOLIO

16.15.4 RECENT DEVELOPMENTS

16.16 BIONIME CORPORATION

16.16.1 COMPANY SNAPSHOT

16.16.2 REVENUE ANALYSIS

16.16.3 PRODUCT PORTFOLIO

16.16.4 RECENT DEVELOPMENTS

16.17 NOVA BIOMEDICAL

16.17.1 COMPANY SNAPSHOT

16.17.2 PRODUCT PORTFOLIO

16.17.3 RECENT DEVELOPMENTS

16.18 CARDINAL HEALTH.

16.18.1 COMPANY SNAPSHOT

16.18.2 REVENUE ANALYSIS

16.18.3 PRODUCT PORTFOLIO

16.18.4 RECENT DEVELOPMENTS

16.19 ORASURE TECHNOLOGIES

16.19.1 COMPANY SNAPSHOT

16.19.2 REVENUE ANALYSIS

16.19.3 PRODUCT PORTFOLIO

16.19.4 RECENT DEVELOPMENTS

16.2 BIOLYTICAL LABORATORIES INC.

16.20.1 COMPANY SNAPSHOT

16.20.2 PRODUCT PORTFOLIO

16.20.3 RECENT DEVELOPMENTS

16.21 EVERLYWELL, INC.

16.21.1 COMPANY SNAPSHOT

16.21.2 PRODUCT PORTFOLIO

16.21.3 RECENT DEVELOPMENTS

16.22 SA SCIENTIFIC LTD.

16.22.1 COMPANY SNAPSHOT

16.22.2 PRODUCT PORTFOLIO

16.22.3 RECENT DEVELOPMENTS

16.23 CLEARBLUE (A SUBSIDIARY OF SWISS PRECISION DIAGNOSTICS GMBH)

16.23.1 COMPANY SNAPSHOT

16.23.2 PRODUCT PORTFOLIO

16.23.3 RECENT DEVELOPMENTS

16.24 BIOSYNEX

16.24.1 COMPANY SNAPSHOT

16.24.2 PRODUCT PORTFOLIO

16.24.3 RECENT DEVELOPMENTS

16.25 PRIMA LAB SA

16.25.1 COMPANY SNAPSHOT

16.25.2 PRODUCT PORTFOLIO

16.25.3 RECENT DEVELOPMENTS

16.26 MP BIOMEDICALS.

16.26.1 COMPANY SNAPSHOT

16.26.2 PRODUCT PORTFOLIO

16.26.3 RECENT DEVELOPMENTS

16.27 STERILAB SERVICES

16.27.1 COMPANY SNAPSHOT

16.27.2 PRODUCT PORTFOLIO

16.27.3 RECENT DEVELOPMENTS

16.28 CHEMBIO DIAGNOSTICS, INC.

16.28.1 COMPANY SNAPSHOT

16.28.2 REVENUE ANALYSIS

16.28.3 PRODUCT PORTFOLIO

16.28.4 RECENT DEVELOPMENTS

16.29 BIOSURE

16.29.1 COMPANY SNAPSHOT

16.29.2 PRODUCT PORTFOLIO

16.29.3 RECENT DEVELOPMENTS

16.3 SELFDIAGNOSTICS OU

16.30.1 COMPANY SNAPSHOT

16.30.2 PRODUCT PORTFOLIO

16.30.3 RECENT DEVELOPMENTS

17 QUESTIONNAIRE

18 RELATED REPORTS

List of Table

TABLE 1 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 2 MIDDLE EAST & AFRICA GLUCOSE TESTS IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 3 MIDDLE EAST & AFRICA INFECTIOUS DISEASES IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 4 MIDDLE EAST & AFRICA PREGNANCY TEST IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 5 MIDDLE EAST & AFRICA DRUG ABUSE TEST KITS IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 6 MIDDLE EAST & AFRICA HIV TEST KIT IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 7 MIDDLE EAST & AFRICA OVULATION PREDICTOR TEST KIT IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 8 MIDDLE EAST & AFRICA OTHERS TEST TYPES IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 9 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 10 MIDDLE EAST & AFRICA CASSETTES IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA STRIP IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA STRIP IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 14 MIDDLE EAST & AFRICA MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA DIP CARD IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA DIP CARD IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA TEST PANEL IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA TEST PANEL IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA OTHERS IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA ADULT IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA GERIATRIC IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA PEDIATRIC IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2020-2029 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA BLOOD IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA URINE IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA SALIVA IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA OTHER SAMPLE TYPES IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY USAGE, 2020-2029 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA DISPOSABLE IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA REUSABLE IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA RETAIL PHARMACIES IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA ONLINE PHARMACIES IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 MIDDLE EAST & AFRICA DRUG STORE IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 MIDDLE EAST & AFRICA SUPERMARKET/HYPERMARKET IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 38 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 39 MIDDLE EAST AND AFRICA AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 40 MIDDLE EAST AND AFRICA AT-HOME TESTING KITS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 41 MIDDLE EAST AND AFRICA STRIPS IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 42 MIDDLE EAST AND AFRICA CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 43 MIDDLE EAST AND AFRICA MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 44 MIDDLE EAST AND AFRICA DIP CARD IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 45 MIDDLE EAST AND AFRICA TEST PANEL IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 46 MIDDLE EAST AND AFRICA AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (USD MILLION)

TABLE 47 MIDDLE EAST AND AFRICA AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2020-2029 (USD MILLION)

TABLE 48 MIDDLE EAST AND AFRICA AT-HOME TESTING KITS MARKET, BY USAGE, 2020-2029 (USD MILLION)

TABLE 49 MIDDLE EAST AND AFRICA AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 50 SOUTH AFRICA AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 51 SOUTH AFRICA AT-HOME TESTING KITS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 52 SOUTH AFRICA STRIPS IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 53 SOUTH AFRICA CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 54 SOUTH AFRICA MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 55 SOUTH AFRICA DIP CARD IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 56 SOUTH AFRICA TEST PANEL IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 57 SOUTH AFRICA AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (USD MILLION)

TABLE 58 SOUTH AFRICA AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2020-2029 (USD MILLION)

TABLE 59 SOUTH AFRICA AT-HOME TESTING KITS MARKET, BY USAGE, 2020-2029 (USD MILLION)

TABLE 60 SOUTH AFRICA AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 61 SAUDI ARABIA AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 62 SAUDI ARABIA AT-HOME TESTING KITS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 63 SAUDI ARABIA STRIPS IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 64 SAUDI ARABIA CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 65 SAUDI ARABIA MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 66 SAUDI ARABIA DIP CARD IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 67 SAUDI ARABIA TEST PANEL IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 68 SAUDI ARABIA AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (USD MILLION)

TABLE 69 SAUDI ARABIA AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2020-2029 (USD MILLION)

TABLE 70 SAUDI ARABIA AT-HOME TESTING KITS MARKET, BY USAGE, 2020-2029 (USD MILLION)

TABLE 71 SAUDI ARABIA AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 72 U.A.E AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 73 U.A.E AT-HOME TESTING KITS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 74 U.A.E STRIPS IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 75 U.A.E CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 76 U.A.E MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 77 U.A.E DIP CARD IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 78 U.A.E TEST PANEL IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 79 U.A.E AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (USD MILLION)

TABLE 80 U.A.E AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2020-2029 (USD MILLION)

TABLE 81 U.A.E AT-HOME TESTING KITS MARKET, BY USAGE, 2020-2029 (USD MILLION)

TABLE 82 U.A.E AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 83 ISRAEL AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 84 ISRAEL AT-HOME TESTING KITS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 85 ISRAEL STRIPS IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 86 ISRAEL CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 87 ISRAEL MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 88 ISRAEL DIP CARD IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 89 ISRAEL TEST PANEL IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 90 ISRAEL AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (USD MILLION)

TABLE 91 ISRAEL AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2020-2029 (USD MILLION)

TABLE 92 ISRAEL AT-HOME TESTING KITS MARKET, BY USAGE, 2020-2029 (USD MILLION)

TABLE 93 ISRAEL AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 94 EGYPT AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 95 EGYPT AT-HOME TESTING KITS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 96 EGYPT STRIPS IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 97 EGYPT CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 98 EGYPT MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 99 EGYPT DIP CARD IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 100 EGYPT TEST PANEL IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 101 EGYPT AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (USD MILLION)

TABLE 102 EGYPT AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2020-2029 (USD MILLION)

TABLE 103 EGYPT AT-HOME TESTING KITS MARKET, BY USAGE, 2020-2029 (USD MILLION)

TABLE 104 EGYPT AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 105 REST OF MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

List of Figure

FIGURE 1 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: MARKET POSITION COVERAGE GRID

FIGURE 7 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: DISTRIBUTOR CHANNEL ANALYSIS

FIGURE 10 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: SEGMENTATION

FIGURE 11 GROWING ADOPTION OF SELF-TESTING KITS IS EXPECTED TO DRIVE MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 GLUCOSE TEST IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY TEST TYPE IN 2022 & 2029

FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE AND ASIA-PACIFIC IS THE FASTEST GROWING REGION IN THE MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET

FIGURE 15 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY TEST TYPE, 2021

FIGURE 16 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY TEST TYPE, 2022-2029 (USD MILLION)

FIGURE 17 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY TEST TYPE, CAGR (2022-2029)

FIGURE 18 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY TEST TYPE, LIFELINE CURVE

FIGURE 19 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY TYPE, 2021

FIGURE 20 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY TYPE, 2022-2029 (USD MILLION)

FIGURE 21 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 22 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 23 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY AGE, 2021

FIGURE 24 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY AGE, 2022-2029 (USD MILLION)

FIGURE 25 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY AGE, CAGR (2022-2029)

FIGURE 26 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY AGE, LIFELINE CURVE

FIGURE 27 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, 2021

FIGURE 28 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, 2022-2029 (EURO MILLION)

FIGURE 29 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, CAGR (2022-2029)

FIGURE 30 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, LIFELINE CURVE

FIGURE 31 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY USAGE, 2021

FIGURE 32 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY USAGE, 2022-2029 (EURO MILLION)

FIGURE 33 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY USAGE, CAGR (2022-2029)

FIGURE 34 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY USAGE, LIFELINE CURVE

FIGURE 35 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 36 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

FIGURE 37 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 38 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 39 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: SNAPSHOT (2021)

FIGURE 40 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY COUNTRY (2021)

FIGURE 41 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 42 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 43 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY TEST TYPE (2022-2029)

FIGURE 44 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: COMPANY SHARE 2021 (%)

View Infographics

FIGURE 1 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: MARKET POSITION COVERAGE GRID

FIGURE 7 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: DISTRIBUTOR CHANNEL ANALYSIS

FIGURE 10 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: SEGMENTATION

FIGURE 11 GROWING ADOPTION OF SELF-TESTING KITS IS EXPECTED TO DRIVE MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 GLUCOSE TEST IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY TEST TYPE IN 2022 & 2029

FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE AND ASIA-PACIFIC IS THE FASTEST GROWING REGION IN THE MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET

FIGURE 15 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY TEST TYPE, 2021

FIGURE 16 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY TEST TYPE, 2022-2029 (USD MILLION)

FIGURE 17 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY TEST TYPE, CAGR (2022-2029)

FIGURE 18 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY TEST TYPE, LIFELINE CURVE

FIGURE 19 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY TYPE, 2021

FIGURE 20 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY TYPE, 2022-2029 (USD MILLION)

FIGURE 21 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 22 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 23 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY AGE, 2021

FIGURE 24 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY AGE, 2022-2029 (USD MILLION)

FIGURE 25 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY AGE, CAGR (2022-2029)

FIGURE 26 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY AGE, LIFELINE CURVE

FIGURE 27 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, 2021

FIGURE 28 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, 2022-2029 (EURO MILLION)

FIGURE 29 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, CAGR (2022-2029)

FIGURE 30 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, LIFELINE CURVE

FIGURE 31 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY USAGE, 2021

FIGURE 32 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY USAGE, 2022-2029 (EURO MILLION)

FIGURE 33 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY USAGE, CAGR (2022-2029)

FIGURE 34 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY USAGE, LIFELINE CURVE

FIGURE 35 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 36 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

FIGURE 37 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 38 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 39 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: SNAPSHOT (2021)

FIGURE 40 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY COUNTRY (2021)

FIGURE 41 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 42 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 43 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: BY TEST TYPE (2022-2029)

FIGURE 44 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: COMPANY SHARE 2021 (%)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 8500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19